Tian Wu

997 total citations
24 papers, 585 citations indexed

About

Tian Wu is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Tian Wu has authored 24 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Organic Chemistry. Recurrent topics in Tian Wu's work include Extracellular vesicles in disease (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cell death mechanisms and regulation (3 papers). Tian Wu is often cited by papers focused on Extracellular vesicles in disease (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cell death mechanisms and regulation (3 papers). Tian Wu collaborates with scholars based in China, Taiwan and United States. Tian Wu's co-authors include Kenneth D. Paull, Sheng Chu Kuo, Chii M. Lin, Jiansong Fang, Li Gao, Qi Wang, Ling Wang, Shuhuan Fang, Cong Yang and Yunbo Chen and has published in prestigious journals such as Free Radical Biology and Medicine, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Tian Wu

23 papers receiving 565 citations

Peers

Countries citing papers authored by Tian Wu

Since Specialization

Citations

This map shows the geographic impact of Tian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian Wu more than expected).

Fields of papers citing papers by Tian Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian Wu. The network helps show where Tian Wu may publish in the future.

Co-authorship network of co-authors of Tian Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Tian Wu. A scholar is included among the top collaborators of Tian Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian Wu. Tian Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Vivo Reprogramming of Tissue‐Derived Extracellular Vesicles for Treating Chronic Tissue Injury Through Metabolic Engineering 2025 ·Advanced Science ·Meng Zhao, Shuyun Liu, Yizhuo Wang, Peng Lou, (unknown), Tian Wu, Lan Li, (unknown), Jiaying Zhu, Yanrong Lu, Meihua Wan, Jingping Liu	0
2	Neonatal liver-derived FTH1-enriched extracellular vesicles attenuate ferroptosis and ameliorate MASLD pathogenesis 2025 ·Free Radical Biology and Medicine ·Xin Zeng, Wei Jiang, Tian Wu, Lan Li, (unknown), (unknown), Dongbo Wu	1
3	Disease-derived circulating extracellular vesicle preconditioning: A promising strategy for precision mesenchymal stem cell therapy 2024 ·Acta Pharmaceutica Sinica B ·(unknown), Tian Wu, Shuyun Liu, Peng Lou, (unknown), Yizhuo Wang, (unknown), Shu Zhang, Dan Du, (unknown), Meihua Wan, Jingping Liu	5
4	Integrative Proteomic Analysis of Multiple Posttranslational Modifications in Inflammatory Response 2021 ·Genomics Proteomics & Bioinformatics ·Feiyang Ji, (unknown), Huihui Zhu, Zhengyi Jiang, (unknown), Xiaoxi Ouyang, Yiming Lv, Sainan Zhang, Tian Wu, Lanjuan Li	20
5	DDX5-targeting fully human monoclonal autoantibody inhibits proliferation and promotes differentiation of acute promyelocytic leukemia cells by increasing ROS production 2020 ·Cell Death and Disease ·Jing Wu, (unknown), Yanxiu Ma, Yanhua Kang, Tian Wu, (unknown), Xiaoxiao Hu, (unknown), Yin Huang, Na Zhang, Xiao‐Ben Pan	12
6	Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury 2018 ·Molecules ·(unknown), (unknown), Zipeng Gong, Xian Liu, Tian Wu, Weirong Li, Jiansong Fang, (unknown), Yingfeng Zhang, Wei Zhao, Chenchen Zhu, Qi Wang, Suiqing Mi, Wang Ning-sheng	17
7	Quantitative and Systems Pharmacology 3. Network-Based Identification of New Targets for Natural Products Enables Potential Uses in Aging-Associated Disorders 2017 ·Frontiers in Pharmacology ·Jiansong Fang, Li Gao, (unknown), Qihui Wu, Tian Wu, Jun Wu, Qi Wang, Feixiong Cheng	37
8	Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment 2016 ·Journal of Ethnopharmacology ·Jiansong Fang, Ling Wang, Tian Wu, Cong Yang, Li Gao, Hao-Bin Cai, Junhui Liu, Shuhuan Fang, Yunbo Chen, Wen Tan, Qi Wang	106
9	The imidazo[1,2-a]pyridine ring system as a scaffold for potent dual phosphoinositide-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitors 2015 ·Bioorganic & Medicinal Chemistry Letters ·Markian M. Stec, Kristin L. Andrews, Yunxin Bo, Sean Caenepeel, Hongyu Liao, John D. McCarter, Erin L. Mullady, Tisha San Miguel, Raju Subramanian, Nuria Tamayo, Douglas A. Whittington, Ling Wang, Tian Wu, Leeanne Zalameda, Nancy R. Zhang, Paul E. Hughes, Mark H. Norman	18
10	P450-Mediated O-Demethylated Metabolite Is Responsible for Rat Hepatobiliary Toxicity of Pyridyltriazine-Containing PI3K Inhibitors 2014 ·Toxicological Sciences ·Raju Subramanian, (unknown), Keith Bailey, Dan Branstetter, Nancy Everds, Jian Jiang, Mark H. Norman, (unknown), Gary L. Skiles, (unknown), Markian M. Stec, (unknown), Tian Wu, Xiaochun Zhu, Hervé Lebrec	6
11	Phosphoinositide-3-kinase inhibitors: Evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511 2014 ·Bioorganic & Medicinal Chemistry Letters ·Brian A. Lanman, Anthony B. Reed, Victor J. Cee, Fang‐Tsao Hong, Liping H. Pettus, Ryan P. Wurz, Kristin L. Andrews, Jian Jiang, John D. McCarter, Erin L. Mullady, Tisha San Miguel, Raju Subramanian, Ling Wang, Douglas A. Whittington, Tian Wu, Leeanne Zalameda, (unknown), Andrew S. Tasker, Paul E. Hughes, Mark H. Norman	3
12	Beyond Glass Transitions: Studying the Highly Viscous and Elastic Behavior of Frozen Protein Formulations Using Low Temperature Rheology and Its Potential Implications on Protein Stability 2012 ·Pharmaceutical Research ·Jian Gu, (unknown), Tian Wu, (unknown), (unknown), Michael Eschenberg, Michael Hale, Merrill Goldenberg	13
13	Reactive oxygen species–mitochondria pathway involved in FV-429-induced apoptosis in human hepatocellular carcinoma HepG2 cells 2011 ·Anti-Cancer Drugs ·Zhen Yang, Lei Qiang, Tian Wu, Feihong Chen, Huiying Yang, Qing Zhao, Meijuan Zou, Yajing Sun, Zhiyu Li, Qinglong Guo	9
14	LFG-500, a newly synthesized flavonoid, induced a reactive oxygen species-mitochondria-mediated apoptosis in hepatocarcinoma cells 2011 ·Biomedicine & Preventive Nutrition ·Tian Wu, Lei Qiang, Feihong Chen, Qing Zhao, Zhen Yang, Meijuan Zou, Yajing Sun, Zhiyu Li, Qinglong Guo	13
15	DHF-18, a new synthetic flavonoid, induced a mitochondrial-mediated apoptosis of hepatocarcinoma cells in vivo and in vitro 2010 ·European Journal of Pharmacology ·Linbo Zhang, Lei Qiang, Feihong Chen, Tian Wu, Jingjing Rong, Qing Zhao, Meijuan Zou, Zhen Yang, Qidong You, Zhiyu Li, Yulin Wu, Qinglong Guo	7
16	Reactive oxygen species-mitochondria pathway involved in LYG-202-induced apoptosis in human hepatocellular carcinoma HepG2 cells 2010 ·Cancer Letters ·Feihong Chen, Linbo Zhang, Lei Qiang, Zhen Yang, Tian Wu, Meijuan Zou, Lei Tao, Qidong You, Zhiyu Li, Yong Yang, Qinglong Guo	45
17	Synthesis of Gingerdione Derivatives as Potent Antiplatelet Agents 2002 ·Zhōnghuá yàoxué zázhì ·(unknown), Li Huang, (unknown), Tian Wu, Che‐Ming Teng, Sheng Chu Kuo	3
18	Synthesis and Anti-platelet Activity of Ferulamide Derivatives 2002 ·Zhōnghuá yàoxué zázhì ·(unknown), Li Huang, (unknown), Tian Wu, Che‐Ming Teng, Sheng Chu Kuo	2
19	Isolation and phytotoxic effects of helvolic acid from plant pathogenic fungus Sarocladium oryzae 1997 ·Zhōngyāng yánjiūyuàn zhíwùxué huikān/Zhōngyāng yánjiūyuàn zhíwùxué huikān ·(unknown), (unknown), (unknown), Tian Wu	30
20	Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4'-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulin 1993 ·Journal of Medicinal Chemistry ·Sheng Chu Kuo, (unknown), (unknown), (unknown), Tian Wu, (unknown), (unknown), Kenneth D. Paull, Chii M. Lin	185

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact